ConcertAI

What it does

ConcertAI is an AI-native oncology real-world evidence and data intelligence platform that connects de-identified patient-level clinical data, genomic sequencing results, and treatment outcome information from health systems and cancer centers - giving pharmaceutical companies and researchers access to the real-world cancer patient data needed to design better clinical trials, identify biomarker-driven patient segments, and generate post-approval evidence for regulators and payers. AI capabilities include NLP extraction of structured cancer data from unstructured clinical notes, machine learning patient matching for clinical trial eligibility screening, AI-powered treatment outcome analysis comparing regimen effectiveness across real-world patient populations, and predictive enrollment modeling for oncology trial site selection.

Strengths

• Pharmaceutical companies, biotech firms, and academic cancer centers use ConcertAI for oncology real-world evidence - AI-extracted patient data informing trial design, biomarker discovery, and regulatory submissions.
• ConcertAI is an AI-native oncology real-world evidence and data intelligence platform that connects de-identified patient-level clinical data, genomic sequencing results, and treatment outcome information from health systems and cancer centers - giving pharmaceutical companies and researchers access to the real-world cancer patient data needed to design better clinical trials, identify biomarker-driven patient segments, and generate post-approval evidence for regulators and payers.
• AI capabilities include NLP extraction of structured cancer data from unstructured clinical notes, machine learning patient matching for clinical trial eligibility screening, AI-powered treatment outcome analysis comparing regimen effectiveness across real-world patient populations, and predictive enrollment modeling for oncology trial site selection.

Watch-outs

• Oncology specialty focus: ConcertAI is purpose-built for oncology drug development and cancer care — pharmaceutical companies outside oncology and non-cancer therapeutic areas have limited applicable use cases.
• Data access is the key dependency: ConcertAI's value depends on its connected health system and cancer center data network — research questions requiring patient populations outside the network cannot be answered by the platform.
• Regulatory validation requirements: Real-world evidence used in regulatory submissions requires extensive validation and expert biostatistician involvement — ConcertAI accelerates the analysis but does not eliminate regulatory expertise requirements.

Pricing

ConcertAI enterprise contracts not published. Pharmaceutical research contracts based on study scope, data access, and analysis requirements. Annual contracts.